Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

Figure 1

Intestinal permeability after 14 days of FEC60. Decreased intestinal permeability after 14 days of FEC60. Small intestinal permeability was probed by measuring the urinary cumulative 5-hour amount of lactulose (Lactulose% = percentage of ingested lactulose), mannitol (Mannitol% = percentage of ingested mannitol) and the Lactulose to Mannitol ratio. Data are reported as medians and the range and analyzed with Wilcoxon matched-pairs signed rank test.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us